Is the R&D credit the same as the R&D deduction?

No. Section 41 provides a credit — a dollar-for-dollar tax reduction — computed on qualified research expenses. Sections 174 and 174A govern the deduction side: whether research costs are expensed immediately or capitalized and amortized. A company can have large Section 174A deductions and no credit, but creditable expenses must be Section 174-type expenditures.

Why are QREs smaller than Section 174 costs?

Section 174/174A reaches all costs incident to research — overhead, rent, utilities, depreciation on research equipment, foreign research, and patent costs. Section 41 counts only in-house wages, supplies, 65% of contract research, and computer rental, only for domestic research passing the four-part test. QREs are therefore a strict subset of SRE costs.

How does Section 280C connect the credit and the deduction?

Section 280C(c) prevents claiming both a deduction and a credit on the same dollars: the taxpayer either reduces its Section 174A deduction (or capitalized amount) by the research credit, or elects a reduced credit equal to 79% of the gross amount. The election must be made on a timely filed original return.

The research credit and Section 174 are different regimes

Two Code provisions govern research spending, and conflating them is the most common error in this area. Section 41 provides the research credit: a dollar-for-dollar tax reduction on a narrowly defined set of qualified research expenses. Sections 174 and 174A provide the deduction rules: whether research costs reduce taxable income now or are capitalized and amortized. They share vocabulary and history, and Section 280C forces them to acknowledge each other — but they are separate regimes with separate definitions, elections, and stakes.

Two regimes, one nervous 2022–2024 interlude

The deduction side has had a turbulent decade. From 1954 through 2021, Section 174 allowed immediate expensing of research or experimental expenditures. The TCJA's delayed time bomb detonated in 2022: for tax years 2022–2024, all specified research or experimental (SRE) expenditures — explicitly including software development — were capitalized, amortized over five years domestic (with a half-year midpoint convention) and fifteen years foreign. The OBBBA, enacted July 4, 2025, ended the domestic half of that experiment with new Section 174A: domestic R&E expenditures are again immediately deductible for tax years beginning after December 31, 2024, with an optional election to amortize over at least 60 months. Foreign research remains on 15-year capitalization under Section 174. Small businesses (average annual gross receipts of $31 million or less) may apply Section 174A retroactively to 2022–2024 by amended return, and all taxpayers may recover remaining unamortized domestic 2022–2024 amounts over one or two years beginning in 2025. The mechanics live in Section 174A explained.

Through all of it, Section 41 did not change. The credit was computed the same way in 2021, 2023, and 2026; what changed was only when the underlying costs hit the income statement for tax purposes.

Why QREs are a subset of SRE costs

The linkage runs one direction. To be a QRE, an expense must be of a kind eligible for Section 174-type treatment — the credit's first test incorporates the deduction's definition. But the credit then narrows the set along three dimensions:

Cost type. Section 174A reaches all costs incident to research: overhead, rent, utilities, depreciation on lab equipment, patent-obtaining costs. Section 41 counts only four categories — wages, supplies, 65% of contract research, computer rental.
Geography. Foreign research is capitalized over 15 years under Section 174 but generates zero QREs.
Activity. Section 174's uncertainty standard is broader than the four-part test; the credit adds the process-of-experimentation, substantially-all, and technological-in-nature requirements, plus the Section 41(d)(4) exclusions (funded research, internal-use software, post-commercial-production work).

The practical consequence cuts both ways. A company's SRE pool is the ceiling on its QRE pool, so a credit study should reconcile to the 174A numbers — QREs exceeding identified SRE costs is a red flag examiners understand. Conversely, claiming the credit is affirmative evidence the taxpayer has Section 174-type costs, which mattered acutely during the 2022–2024 capitalization years (the credit claim proved the amortization obligation) and still matters for taxpayers electing 60-month amortization or holding foreign research.

Section 280C: the anti-double-dip

The regimes meet in Section 280C(c). Because a wage dollar can be both deducted under 174A and credited under 41, the Code makes the taxpayer choose: reduce the deduction (or the capitalized amount, for costs being amortized) by the credit, or elect the reduced credit — the gross credit times (1 − 21%), i.e., 79%. At the 21% corporate rate the two are economically equivalent federally; the election usually wins on state simplicity and must be made on a timely filed original return, a deadline that quietly penalizes retroactive claims. The full arithmetic is in how to calculate the credit.

Keeping the regimes straight in practice

Three rules of thumb. First, compute 174A before 41: identify the SRE pool, then carve the QREs from inside it, and keep the reconciliation in the workpapers. Second, do not let the credit study drive the deduction characterization — costs are SRE or not based on Section 174A's own standard, whether or not anyone claims a credit. Third, remember the regimes' stakes differ: the deduction question is timing (when income is offset), while the credit is permanent benefit — which is why a marginal project that is clearly deductible may still not be worth pushing through the credit's documentation gauntlet. For the underlying concept, see credits versus deductions.